Table 3 Characteristics of interventions (N = 740)
Drug-related problem | Interventions n (%) | Drugs involved | |
|---|---|---|---|
No specific problem*,1 | 118 | (15.9) | antibacterials for systemic use, psycholeptics, drugs used in diabetes, diuretics |
Prescription writing error | 89 | (12.0) | beta blocking agents, anti-parkinson drugs, psycholeptics |
Inappropriate follow-up | 83 | (11.2) | drugs used in diabetes, psychoanaleptics, drugs for acid related disorders, calcium channel blockers |
Less costly alternative | 74 | (10.0) | drugs for acid related disorders, lipid modifying agents, psycholeptics, vitamins |
Error in medication history | 72 | (9.7) | anti-parkinson drugs, analgesics, beta blocking agents, psychoanaleptics |
Wrong dose | 66 | (8.9) | cardiac therapy (digoxin), drugs used in diabetes, vitamins, beta blocking agents |
Underuse | 54 | (7.3) | antianemic preparations, lipid modifying agents |
Inappropriate choice of medicine | 37 | (5.0) | antibacterials for systemic use, antithrombotic agents, psycholeptics |
Inappropriate modalities of administration*,2 | 36 | (4.9) | antibacterials for systemic use, analgesics |
Drug-drug interaction | 20 | (2.7) | Analgesics |
Adverse drug reaction suspected or confirmed*,3 | 16 | (2.2) | psycholeptics, psychoanaleptics*,4 |
Duplication | 15 | (2.0) | drugs for acid related disorders, drugs for obstructive airway diseases |
Inappropriate duration of therapy | 12 | (1.6) | Vitamins |
No valid indication | 12 | (1.6) | Miscellaneous |
Modalities of administration not practical for the patient | 8 | (1.1) | Miscellaneous |
Drug-disease interaction (including allergy) | 6 | (0.8) | Miscellaneous |
Other | 22 | (3.0) | Miscellaneous |